What this trial means for you
This study is recruiting now at 24 US sites. It's studying NNC0662-0419, Semaglutide, NNC0662-0419 Placebo, Semaglutide placebo for obesity.
What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study, ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.
The study, in the sponsor's words
The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Can you join? The exact criteria
Below is the verbatim eligibility text from the registry. Bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.
Full eligibility criteria (for you and your doctor)
Inclusion Criteria: * Male or female (sex assigned at birth, inclusive of all gender identities). * Age 18 years or above at the time of signing the informed consent. * Body mass index (BMI) greater than or equal to (≥) 30.0 kilogram per square meter (kg/m\^2) at screening. * Participant must have a desire and be committed to lose at least 25 percentage (%) of their body weight from randomisation. Exclusion Criteria: * Known or suspected hypersensitivity to study intervention(s) or related products. * Treatment with any medication prescribed for the indication of obesity or weight management (e.g. glucagon-like-peptide-1 (GLP-1) receptor agonists (RA), dual GLP-1/gastric inhibitory peptide (GIP) RAs (or any other GLP-1 based treatment) or amylin analogues)) within 90 days before screening. * Glycated haemoglobin (HbA1c) ≥ 6.5% (48 Millimoles per mole \[mmol/mol\]) as measured by the central laboratory at screening. * History of type 1 or type 2 diabetes mellitus.
Study sites by state
Alabama
- Chambliss Clinical Trials, LLC, Montgomery · Recruiting now
California
- FDRC, Costa Mesa · Recruiting now
- Los Angeles Institute for Metabolic Research, Los Angeles · Recruiting now
Florida
- Encore Medical Research LLC, Hollywood · Recruiting now
- South Broward Research LLC, Miramar · Recruiting now
- West Orange Endocrinology, Ocoee · Recruiting now
Illinois
- Cedar-Crosse Research Center, Chicago · Recruiting now
- Great Lakes Clinical Trials, Chicago · Recruiting now
Indiana
- Midwest Inst For Clin Res, Indianapolis · Opening soon
Kentucky
- L-MARC Research Center, Louisville · Recruiting now
Maryland
- Endo And Metab Cons, Rockville · Recruiting now
Missouri
- StudyMetrix Research LLC, City of Saint Peters · Recruiting now
New York
- Great Lakes Medical Research, Westfield · Recruiting now
North Carolina
- KDCILM, LLC & Accellacare US, Inc., Wilmington · Recruiting now
Ohio
- Family Practice Center of Wadsworth Inc., Wadsworth · Recruiting now
Pennsylvania
- UPA Ctr Weight and Eating Dis, Philadelphia · Recruiting now
Rhode Island
- Clinical Res Collaborative, Cumberland · Recruiting now
Tennessee
- Holston Medical Group_Bristol, Bristol · Recruiting now
- Holston Medical Group, Kingsport · Recruiting now
- Clinical Research Associates, Nashville · Recruiting now
Texas
- PlanIt Research, PLLC, Houston · Recruiting now
- Pinnacle Clinical Research, San Antonio · Recruiting now
Virginia
- National Clin Res Inc., Richmond · Recruiting now
Washington
- Rainier Clin Res Ctr Inc, Renton · Recruiting now
View the official record on ClinicalTrials.gov →
Follow this trial
Get an email when our monthly digest covers enrollment changes and results for trials like this one.